<SEC-DOCUMENT>0001193125-22-039609-index.html : 20220214
<SEC-HEADER>0001193125-22-039609.hdr.sgml : 20220214
<ACCEPTANCE-DATETIME>20220214080153
ACCESSION NUMBER:		0001193125-22-039609
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20220214
DATE AS OF CHANGE:		20220214
GROUP MEMBERS:		BOSTON BIOTECH VENTURES, LLC
GROUP MEMBERS:		OCHA LLC

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Moderna, Inc.
		CENTRAL INDEX KEY:			0001682852
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				813467528
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-90749
		FILM NUMBER:		22625368

	BUSINESS ADDRESS:	
		STREET 1:		200 TECHNOLOGY SQUARE
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		6177146500

	MAIL ADDRESS:	
		STREET 1:		200 TECHNOLOGY SQUARE
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Moderna Therapeutics, Inc.
		DATE OF NAME CHANGE:	20160822

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bancel Stephane
		CENTRAL INDEX KEY:			0001443340

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	MAIL ADDRESS:	
		STREET 1:		320 BENT STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>d283352dsc13ga.htm
<DESCRIPTION>SC 13G/A
<TEXT>
Document 1 - file: d283352dsc13ga.htm

</DOCUMENT>
</SEC-DOCUMENT>